The cost can also add up
Additionally, no association was observed between the use of GLP-1 RAs and the incidence of sunburn, herniated intervertebral discs, traffic accidents, or pneumonia
refer to COA for component ratio per capsule) Strength: 2 mg total peptide content per capsule Count: 60 capsules per bottle Purity: 99% (HPLC verified, each component) Container: sealed amber bottle Certificate of Analysis: lot-specific COA available, with separate purity and identity verification for all three component peptides See the FDA Disclosure, Storage Instructions, and RUO tabs for handling, storage, and regulatory information
requires continuous treatment adherence, logged weights in patient portal, and provider check-ins
14.5 MOUNJARO Use in Combination with Metformin or Basal Insulin, or Both in Pediatric Patients 10 Years of Age and Older with Type 2 Diabetes Mellitus SURPASS-PEDS (NCT05260021) was a 30-week double-blind, placebo-controlled trial with a 22-week open-label extension that randomized 99 pediatric patients 10 years of age and older with type 2 diabetes mellitus with inadequate glycemic control on metformin (69%), or basal insulin (8%), or both (23%) to receive subcutaneous MOUNJARO 5 mg, MOUNJARO 10 mg, or placebo once weekly as add-on therapy
